Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Tuesday, March 25, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Mortality, Hospitalizations, and Urgent Heart Failure in Patients with ATTR-CM
Life Sciences Times
-
March 23, 2025
Pharma
Symbiosis Pharmaceutical Services Completes Successful FDA Regulatory Inspection
Life Sciences Times
-
March 23, 2025
Pharma
New US product launch, VENXXIVA™ (tiopronin) Delayed-Release Tablets for the treatment of cystinuria
Life Sciences Times
-
March 18, 2025
Pharma
Corsair Pharma Announces Successful Completion of Preclinical Program for Its Treprostinil Prodrug Transdermal System
Life Sciences Times
-
March 17, 2025
Pharma
Shorla Oncology Announces Expansion of U.S. Commercial Footprint with Launch of Dedicated Sales Force and Market Access Teams
Life Sciences Times
-
March 4, 2025
Pharma
Lantern Pharma’s Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA
Life Sciences Times
-
October 15, 2024
0
Pharma
PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults
Life Sciences Times
-
September 27, 2024
0
Pharma
Thermo Fisher Scientific Expands Oral Solid Dose Development and Manufacturing Capabilities Across North America
Life Sciences Times
-
September 26, 2024
0
Pharma
Aptar Pharma Enters into Exclusive Agreement with Pulmotree to Develop and Promote Kolibri™ Non-Propellant Liquid Inhaler Platform
Life Sciences Times
-
September 10, 2024
0
Pharma
ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics
Life Sciences Times
-
September 10, 2024
0
Pharma
Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan)
Life Sciences Times
-
September 6, 2024
0
Pharma
Vetter’s European Clinical Site Successfully Completes First 100 Aseptic Fills
Life Sciences Times
-
September 5, 2024
0
Pharma
IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer’s Disease
Life Sciences Times
-
September 4, 2024
0
Pharma
Transforming the Future of Medicine with RNA-Based Therapies
Life Sciences Times
-
August 27, 2024
0
Pharma
Opna Bio Doses First Patient in Phase 1 Study in Multiple Myeloma with OPN-6602, an EP300/CBP Bromodomain Inhibitor
Life Sciences Times
-
August 26, 2024
0
Pharma
Pfizer Announces Top-Line Results of ABRYSVO® for RSV in Immunocompromised Adults
Life Sciences Times
-
August 12, 2024
0
Pharma
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate
Life Sciences Times
-
August 12, 2024
0
1
2
3
...
60
Page 2 of 60
Most Read
BioMed Realty Acquires 75 Broadway, a Life Science Development to be Biogen’s New Global Headquarters
March 25, 2025
athenahealth Releases Annual Physician Survey
March 25, 2025
Character Biosciences Raises $93 Million Series B to Advance Precision Medicine for Progressive Eye Diseases
March 25, 2025
Suffolk Hires Experienced Construction Leader Evan McKee as COO in Dallas to Drive Regional Growth and Diversification
March 25, 2025